• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

Agenda for the Aug. 16, 2013 Meeting of the Risk Communication Advisory Committee

FDA White Oak Campus, 10903 New Hampshire Ave., Bldg. 31,
Conference Center (Rm. 1503), Silver Spring, MD

9:00 Admin

9:05 FDA Welcome and Update

Ji Sun Lee, Director, Risk Communication Staff, Office of Planning

9:10  CDER Presentation

Connie Jung, Acting Associate Director, Policy and Communication, Office of Drug Security, Integrity, and Recalls

9:30 Guest Speaker

Bryan E. Smith, Counsel, Allergan, Inc.

9:45 Committee Questions and Discussion

Discussion Topic: Part 1

  • Measuring effectiveness and impact of awareness letters

10:45 Break

11:00 Committee Questions and Discussion*

Discussion Topic: Part 2

  • Measuring effectiveness and impact of public health alerts

12:00 Lunch (On your own)

1:00 Open Public Hearing

2:00 Committee Questions and Discussion*

Discussion Topic: Part 3

  • Resources and communications vehicles for specific targeted populations

2:45 Committee Questions and Discussion* 

Discussion Topic: Part 4

  • Stakeholder Communication barriers

* Times for discussion periods may vary as needed.